Dexcom (DXCM) Amortization of Deferred Charges (2010 - 2016)

Dexcom (DXCM) has reported Amortization of Deferred Charges for 6 consecutive years, with $100000.0 the latest figure, recorded in Q3 2016.

• On a quarterly basis, Amortization of Deferred Charges changed 0.0% year-over-year to $100000.0 in Q3 2016; TTM through Sep 2016 was $100000.0, a 50.0% decrease from a year earlier, with the FY2015 full-year figure at $200000.0, down 33.33% from the prior year.
• Amortization of Deferred Charges was $100000.0 for Q3 2016 at Dexcom, roughly flat from $100000.0 in the prior quarter.
• Over five years, Amortization of Deferred Charges peaked at $200000.0 in Q2 2013 and troughed at $100000.0 in Q4 2012.
• A 5-year average of $110000.0 and a median of $100000.0 in 2012 frame the typical range for Amortization of Deferred Charges.
• Across the five-year window, Amortization of Deferred Charges changed 0.0% in 2013 and sank 50.0% in 2014, its largest moves.
• Over 5 years, Amortization of Deferred Charges stood at $100000.0 in 2012, then changed by 0.0% to $100000.0 in 2013, then changed by 0.0% to $100000.0 in 2014, then changed by 0.0% to $100000.0 in 2015, then changed by 0.0% to $100000.0 in 2016.
• The last three Amortization of Deferred Charges figures came in at $100000.0 (Q3 2016), $100000.0 (Q3 2015), and $100000.0 (Q1 2015), per Business Quant data.